Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Chen

Showing results (141-150 of 274) with videos related to

Pageof 28
Sort By:
Neurology|August 30, 2022
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein PathologyKatheryn Alexandra Quilico Cousins, Sanaz Arezoumandan, Sanjana Shellikeri, et al.
Journal of the National Cancer Institute|February 6, 2016
Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination RepairMiguel A Villalona-Calero, Wenrui Duan, Weiqiang Zhao, et al.
Nature Communications|October 25, 2018
Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicityChia-Yu Chung, Amit Berson, Jason R Kennerdell, et al.
Nature Communications|January 31, 2019
Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicityChia-Yu Chung, Amit Berson, Jason R Kennerdell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Journal of the Neurological Sciences|August 28, 2013
Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's diseaseMark Yarchoan, Natalia Louneva, Sharon X Xie, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Tau Burden is Best Captured by Magnitude and Extent: Tau-MaX as a Measure of Global TauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Ebiomedicine|July 22, 2022
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageLeah Zuroff, Ayman Rezk, Koji Shinoda, et al.
Acta Neuropathologica|July 24, 2010
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's diseaseWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Pageof 28

Showing results (141-150 of 274) with videos related to

Sort By:
Pageof 28
Neurology|August 30, 2022
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein PathologyKatheryn Alexandra Quilico Cousins, Sanaz Arezoumandan, Sanjana Shellikeri, et al.
Journal of the National Cancer Institute|February 6, 2016
Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination RepairMiguel A Villalona-Calero, Wenrui Duan, Weiqiang Zhao, et al.
Nature Communications|October 25, 2018
Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicityChia-Yu Chung, Amit Berson, Jason R Kennerdell, et al.
Nature Communications|January 31, 2019
Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicityChia-Yu Chung, Amit Berson, Jason R Kennerdell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Journal of the Neurological Sciences|August 28, 2013
Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's diseaseMark Yarchoan, Natalia Louneva, Sharon X Xie, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Tau Burden is Best Captured by Magnitude and Extent: Tau-MaX as a Measure of Global TauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Ebiomedicine|July 22, 2022
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageLeah Zuroff, Ayman Rezk, Koji Shinoda, et al.
Acta Neuropathologica|July 24, 2010
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's diseaseWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Pageof 28